Jun 29, 2018
This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in...
Jun 15, 2018
This podcast discusses controversies in lipid management, including the safety of very low low-density lipoprotein cholesterol levels, the role of PCSK9 in high-risk patients for primary prevention, and the use of formal risk assessment and imaging in primary prevention.